07:24 AM EDT, 09/11/2025 (MT Newswires) -- KalVista Pharmaceuticals ( KALV ) reported a fiscal Q1 net loss Thursday of $1.12 per diluted share, wider than the loss of a $0.87 loss a year earlier.

An analyst polled by FactSet expected a loss of $0.95.

Net product revenue for the fiscal quarter ended July 31 was $1.4 million. The company did not report revenue a year earlier.

Analysts surveyed by FactSet expected $700,000.

The company said that as of July 31, it had cash, cash equivalents, and marketable securities of about $191.5 million, expected to fund operations into 2027.